Evidence map›Paper›PMID 24371556›Full record

ArticleResults in immunology2011

Identification of a mechanism for lung inflammation caused by Mycoplasma pneumoniae using a novel mouse model.

Takeshi Saraya, Koh Nakata, Kazuhide Nakagaki, Natsuki Motoi, Kuniko Iihara, Yasunori Fujioka, Teruaki Oka, Daisuke Kurai, Hiroo Wada, Haruyuki Ishii and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Results in immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. The Post-Pandemic Return ofJournal of clinical medicine · 2026
    Article
  2. Molecules (Basel, Switzerland) · 2023
    Article
  3. Review
  4. Article
  5. Current perspectives on atypical pneumonia in children.Clinical and experimental pediatrics · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Journal of general and family medicine · 2017
    Review
  11. Review
  12. A Compendium for Mycoplasma pneumoniae.Frontiers in microbiology · 2016
    Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Takeshi SarayaDepartment of Respiratory Medicine, Kyorin University School of Medicine, 6-20-2, Shinkawa, Mitaka City, Tokyo, Japan.
Koh NakataNiigata University Medical & Dental Hospital, Bioscience Medical Research Center, 1-754, Asashimachi-dori, Chuo-ku, Niigata 951-8520, Japan.
Kazuhide NakagakiLaboratory of Infectious Diseases and Immunology, College of Veterinary Medicine, Nippon Jui Seimei-kagaku University, Musashino, Tokyo 180-8602, Japan.
Natsuki MotoiNiigata University Medical & Dental Hospital, Bioscience Medical Research Center, 1-754, Asashimachi-dori, Chuo-ku, Niigata 951-8520, Japan.
Kuniko IiharaNTT Medical Center Tokyo, Department of Diagnostic Pathology, Japan.
Yasunori FujiokaDepartment of Pathology, Kyorin University School of Medicine, Japan.
Teruaki OkaDivision of Pathology and Central Clinical Laboratory, Kanto Central Hospital of the Mutual Aid Association of Public School Teachers, Japan.
Daisuke KuraiDepartment of Respiratory Medicine, Kyorin University School of Medicine, 6-20-2, Shinkawa, Mitaka City, Tokyo, Japan.
Hiroo WadaDepartment of Respiratory Medicine, Kyorin University School of Medicine, 6-20-2, Shinkawa, Mitaka City, Tokyo, Japan.
Haruyuki IshiiDepartment of Respiratory Medicine, Kyorin University School of Medicine, 6-20-2, Shinkawa, Mitaka City, Tokyo, Japan.
Haruhiko TaguchiDepartment of Immunology, Kyorin University, Faculty of Health Sciences, Japan.
Shigeru KamiyaDepartment of Infectious Diseases, Kyorin University School of Medicine, 6-20-2, Shinkawa, Mitaka City, Tokyo, Japan.
Hajime GotoDepartment of Respiratory Medicine, Kyorin University School of Medicine, 6-20-2, Shinkawa, Mitaka City, Tokyo, Japan.
Kyorin University · JPNiigata University Medical and Dental Hospital · JPKanto Central Hospital · JPNTT Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human Mycoplasma pneumoniae (MP) pneumonia is characterized by alveolar infiltration with neutrophils and lymphocytes and lymphocyte/plasma cell infiltrates in the peri-bronchovascular area (PBVA). No mouse model has been able to mimic the pathological features seen in human MP pneumonia, such as plasma cell-rich lymphocytic infiltration in PBVA. To figure out the mechanism for inflammation by MP infection using a novel mouse model that mimics human MP pneumonia, mice were pre-immunized intraperitoneally with Th2 stimulating adjuvant, alum, alone or MP extracts with an alum, followed by intratracheal challenge with MP extracts. The toll-like receptor-2, which is the major receptor for mycoplasma cell wall lipoproteins, was strongly up-regulated in alveolar macrophages in a latter group after the pre-immunization but prior to the intratracheal challenge. Those findings demonstrated that acceleration of innate immunity by antecedent antigenic stimulation can be an important positive-feedback mechanism in lung inflammation during MP pneumonia.

Indexed as

Alveolar macrophageAMs, alveolar macrophageBAL, bronchoalveolar lavageIT, intratracheal challengeMice modelMP, Mycoplasma pneumoniaeMP pneumonia, Mycoplasma pneumoniaMycoplasma pneumoniae pneumoniaMycoplasma pneumonia extractsPBA, peribronchiolare areaPBVA, peri-bronchovascular areaPlasma cellPVA, perivascular areaTLR, Toll-like receptorToll-like receptor-2

Identifiers

PMID24371556
PMCPMC3850488
OpenAlexW1966154088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.